Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment
ICD-10 E09.37 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment.
E09.37 refers to diabetes mellitus that has been induced by drugs or chemicals, which is characterized by the presence of diabetic macular edema. This condition arises when certain medications or substances lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. Diabetic macular edema is a complication of diabetes that affects the retina, leading to vision impairment. In this specific case, the edema has resolved following appropriate treatment, indicating that the underlying diabetes has been managed effectively. Management may include discontinuation of the offending agent, lifestyle modifications, and pharmacological interventions such as insulin therapy or oral hypoglycemics. Monitoring of HbA1c levels is crucial to assess long-term glycemic control and to prevent further complications. The resolution of diabetic macular edema is typically confirmed through ophthalmologic evaluation, emphasizing the importance of interdisciplinary collaboration in managing this condition.
Detailed medication history, HbA1c levels, and treatment plans.
Management of drug-induced diabetes, monitoring of blood glucose levels.
Ensure clear documentation of the drug responsible for diabetes induction.
Ophthalmologic evaluations, imaging results, and treatment outcomes.
Assessment and treatment of diabetic macular edema.
Document resolution of edema and any interventions performed.
Used when a patient with drug-induced diabetes is evaluated for diabetic macular edema.
Document the reason for the examination and findings related to diabetic macular edema.
Ophthalmologists should ensure clear linkage to diabetes management.
Common drugs that can induce diabetes include glucocorticoids, certain antipsychotics, and some medications used in the treatment of HIV. These drugs can cause insulin resistance or impair insulin secretion, leading to elevated blood glucose levels.
